LEGN

Legend Biotech Corporation

45.96 USD
+0.21 (+0.46%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Legend Biotech Corporation stock is up 3.56% since 30 days ago. The next earnings date is Aug 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 4 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 10 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
19 Apr 15:32 19 Apr, 2024 55.00 PUT 39 1367
19 Apr 17:33 19 Apr, 2024 55.00 PUT 31 1367
19 Apr 17:33 19 Apr, 2024 55.00 PUT 46 1367
19 Apr 18:13 19 Apr, 2024 50.00 PUT 100 613
19 Apr 18:32 19 Apr, 2024 50.00 PUT 116 613
19 Apr 18:34 19 Apr, 2024 50.00 PUT 211 613
19 Apr 19:44 19 Apr, 2024 50.00 PUT 100 613
19 Apr 19:44 19 Apr, 2024 50.00 PUT 100 613
02 May 13:31 17 May, 2024 60.00 PUT 18 57
29 May 16:19 21 Jun, 2024 50.00 PUT 40 901

About Legend Biotech Corporation

Legend Biotech Corporation engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for gastric cancer and T cell lymphoma.

  • HC Wainwright & Co.
    Thu Jun 6, 06:51
    buy
    confirm
  • HC Wainwright & Co.
    Tue Jun 4, 06:24
    buy
    confirm
  • HC Wainwright & Co.
    Fri May 24, 06:11
    buy
    confirm
  • Deutsche Bank
    Thu May 23, 13:00
    buy
    initial
  • RBC Capital
    Tue May 14, 11:30
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 14, 06:55
    buy
    confirm